According to a recent article published in the ESHRE journal Focus on REPRODUCTION monitoring Campus workshop in Kempten, Germany, Israeli epidemiologist L. Lerner-Geva’s case studies examination “relative risk – in the association of ovarian cancer with controlled ovarian hyperstimulation – has not been reproduced”. Either US epidemiologist L. Brinton in “her own retrospective study found no statistically signifi cant associations between treatment and breast or ovarian cancers.” Other results showed almost no signifi cance in impact of ART on breast cancer cases. The conclusion of Campus workshop is refl ected in a recommendation “that pre-IVF mammography in nulligravid over 35s makes sense.” ‘It is a small investment to make, and it makes sense given that a first pregnancy after 35 is in itself a risk factor for breast cancer.’ “ as said by R. Felberbaum, Campus organizer. Focus on REPRODUCTION, May 2011